Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons

Azeem Latib; Antonio Mangieri; Felix Sebastian Nettersheim; Stephan Baldus

doi:10.4244/EIJ-E-22-00045

Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons

Azeem Latib, Antonio Mangieri, Felix Sebastian Nettersheim, Stephan Baldus

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1395-1397
Number of pages	3
Journal	EuroIntervention
Volume	18
Issue number	17
DOIs	https://doi.org/10.4244/EIJ-E-22-00045
State	Published - Apr 2023

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.4244/EIJ-E-22-00045

Cite this

@article{83cdd737e4c74194b6e949dd5e55d16f,

title = "Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons",

author = "Azeem Latib and Antonio Mangieri and Nettersheim, {Felix Sebastian} and Stephan Baldus",

note = "Funding Information: A. Latib is on the advisory board and/or has consulted for Edwards Lifesciences, V-dyne, Medtronic, Abbott, and Boston Scientific. A. Mangieri received speaking honoraria from Boston Scientific and Abbott Vascular; fees and speaking honoraria from Concept Medical; and an institutional grant from Boston Scientific.",

year = "2023",

month = apr,

doi = "10.4244/EIJ-E-22-00045",

language = "English (US)",

volume = "18",

pages = "1395--1397",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "17",

}

TY - JOUR

T1 - Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation

T2 - pros and cons

AU - Latib, Azeem

AU - Mangieri, Antonio

AU - Nettersheim, Felix Sebastian

AU - Baldus, Stephan

N1 - Funding Information: A. Latib is on the advisory board and/or has consulted for Edwards Lifesciences, V-dyne, Medtronic, Abbott, and Boston Scientific. A. Mangieri received speaking honoraria from Boston Scientific and Abbott Vascular; fees and speaking honoraria from Concept Medical; and an institutional grant from Boston Scientific.

PY - 2023/4

Y1 - 2023/4

UR - http://www.scopus.com/inward/record.url?scp=85153803828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153803828&partnerID=8YFLogxK

U2 - 10.4244/EIJ-E-22-00045

DO - 10.4244/EIJ-E-22-00045

M3 - Comment/debate

C2 - 37092268

AN - SCOPUS:85153803828

SN - 1774-024X

VL - 18

SP - 1395

EP - 1397

JO - EuroIntervention

JF - EuroIntervention

IS - 17

ER -

Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this